Buy & Sell Diagnos Laboratorium Utama Tbk. - DGNS Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp166.62B | +2.18% |
| Cost of Revenue | Rp87.86B | -2.64% |
| Gross Profit | Rp78.77B | +8.15% |
| General Expenses, Depreciation, Interest | Rp73.47B | +3.66% |
| Operating Profit | Rp5.3B | +170.31% |
| Other Income | Rp107.28M | -109.78% |
| EBT | Rp5.41B | +525.9% |
| Taxes | -Rp2.47B | +2022.76% |
| Net Income | Rp2.94B | +292.95% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp318.67B | +6.22% |
| Total Liabilities | Rp114.68B | +10.39% |
| Total Equity | Rp203.99B | +4.01% |
| Total Liabilities & Total Equity | Rp318.67B | +6.22% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp10.66B | -60.96% |
| CF from Investment | Rp9.23B | -79.12% |
| CF from Financing | Rp2.83B | -73.88% |
| Net Cash Flow | Rp4.27B | -170.67% |